anti-MMP23A antibody product blog
Tags: Antibody; Monoclonal Antibody; anti-MMP23A antibody; MMP23A; Matrix Metalloproteinase 23A (MMP23A);
The MMP23A n/a (Catalog #MBS2085827) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Monoclonal Antibody to Matrix Metalloproteinase 23A (MMP23A) reacts with Pig and may cross-react with other species as described in the data sheet. MyBioSource\'s Matrix Metalloproteinase 23A (MMP23A) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).Western Blot: 0.5-5ug/ml
Immunocytochemistry in formalin fixed cells: 5-30ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-30ug/ml
Immunohistochemistry in paraffin section: 5-30ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml. Researchers should empirically determine the suitability of the MMP23A n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Monoclonal Antibody to Matrix Metalloproteinase 23A (MMP23A) with the following immunoassay(s):
Western Blot (WB) (Western Blot: Sample: Recombinant BDNF, Porcine.)
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MMP23A are readily searchable from our website. Different antibodies against the same target such as MMP23A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.